About the Company
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EXAS News
Exact Sciences (NASDAQ: EXAS)
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called ...
Exact Sciences' (EXAS) BLUE-C Study Results Published in NEJM
Exact Sciences Corporation EXAS recently announced the online publication of the BLUE-C study results in The New England Journal of Medicine (NEJM). The 20,000-participant, multi-center and ...
Q4 2023 Exact Sciences Corp Earnings Call
Brian Baranick; General Manager of Precision Oncology; Exact Sciences Corporation Everett V. Cunningham; Chief Commercial Officer; Exact Sciences Corporation Jeffrey T. Elliott; CFO; Exact ...
Study deeming colon cancer screening device effective published
A device designed to detect colorectal cancer (CRC) has been found to have high detection and sensitivity rates, compared to ...
Exact Sciences Corp EXAS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Buy Rating Affirmed for Exact Sciences Amid Market Expansion and Product Advancement Prospects
Wisconsin-based Exact Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. Read More on EXAS: EXACT Sciences NewsMORE Related ...
Exact Sciences Corporation (EXAS) Q4 2023 Earnings Call Transcript
Good afternoon, and welcome to the Exact Sciences Fourth Quarter 2023 Earnings Call. Please be advised that this call is being recorded. All lines have been placed on mute to prevent any ...
Exact Sciences Corp EXAS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Q4 2023 Exact Sciences Corp Earnings Call
Brian Baranick; General Manager of Precision Oncology; Exact Sciences Corporation Everett V. Cunningham; Chief Commercial Officer; Exact Sciences Corporation Jeffrey T. Elliott; CFO; Exact Sciences ...
Loading the latest forecasts...